marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-31-2024
Alnylam Pharmaceuticals Cash Flow 2011-2024 | ALNY
Annual Cash Flow Alnylam Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
104 M | -541 M | -642 M | -615 M | -278 M | -563 M | -383 M | -308 M | - | - | -68.7 M | -116 M | -87.1 M |
Depreciation & Amortization |
54.1 M | 44.5 M | 47.6 M | 34.8 M | 17.2 M | 15.2 M | 13.4 M | 15.1 M | 19 M | 11.9 M | 10.2 M | 9.04 M | 5.12 M |
Accounts Payables |
55.5 M | 98.1 M | 73.4 M | 52 M | 49.9 M | 59.7 M | 28.4 M | 54.5 M | 16.8 M | 15.1 M | 5.9 M | 4.42 M | 5.8 M |
Accounts Receivables |
99.6 M | 32.3 M | 73.3 M | 33.5 M | 14.9 M | 18.8 M | 34 M | 23.3 M | 8.3 M | 39.9 M | 4.25 M | 104 K | 1.47 M |
Total Inventories |
89.1 M | 129 M | 86.4 M | 75.2 M | 56.3 M | 24.1 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Alnylam Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -81.5 M | - | - | - | -166 M | - | -409 M | - | -171 M | - | -492 M | - | -236 M | - | -492 M | -381 M | -246 M | - | -82.4 M | 100 M | -189 M | - | -412 M | -258 M | -156 M | - | -280 M | -181 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -971 K | - | -46.7 M | -51.9 M | -30.2 M | - | -61.9 M | -32.9 M | -6.3 M |
Depreciation & Amortization |
- | - | 13.5 M | - | - | - | 14.1 M | - | 30.2 M | - | 9.46 M | - | 36.2 M | - | 12.6 M | - | 24.4 M | 15.8 M | 7.61 M | - | 11.7 M | 7.69 M | 3.84 M | - | 5.82 M | 5.42 M | 3.18 M | - | 9.65 M | 6.07 M | 3 M | - | 12.1 M | 8.61 M | 4.6 M | - | 14 M | 8.71 M | 3.69 M | - | 8.58 M | 5.47 M | 2.6 M | - | 7.6 M | 4.84 M | 2.13 M | - | 7.01 M | 4.73 M | 2.12 M | - | 3.89 M | 2.63 M | 1.34 M |
Accounts Payables |
70.8 M | 74 M | 78.1 M | 55.5 M | 73.8 M | 59.7 M | 62.2 M | 98.1 M | 40.6 M | - | 54.9 M | 73.4 M | 40 M | 53.1 M | 45.4 M | 52 M | 52 M | 52 M | 52 M | 49.9 M | 49.9 M | 49.9 M | 49.9 M | 59.7 M | 59.7 M | 59.7 M | 59.7 M | 28.4 M | 28.4 M | 28.4 M | 28.4 M | 54.5 M | 54.5 M | 54.5 M | 54.5 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 15.1 M | 15.1 M | 15.1 M | 15.1 M | 5.9 M | 5.9 M | 5.9 M | 5.9 M | 4.42 M | 4.42 M | 4.42 M | 4.42 M | 5.8 M | 5.8 M | 5.8 M | 5.8 M |
Accounts Receivables |
354 M | 309 M | 321 M | 328 M | 325 M | 221 M | 219 M | 238 M | 21.9 M | - | 23.4 M | 73.3 M | 23.6 M | 33.9 M | 19.1 M | 33.5 M | 33.5 M | 33.5 M | 33.5 M | 14.9 M | 14.9 M | 14.9 M | 14.9 M | 5.62 M | 5.62 M | 5.62 M | 5.62 M | 34 M | 14.6 M | 15.4 M | 34 M | 23.3 M | 23.3 M | 23.3 M | 23.3 M | 8.3 M | 8.3 M | 8.3 M | 8.3 M | 39.9 M | 39.9 M | 39.9 M | 39.9 M | 4.25 M | 4.25 M | 4.25 M | 4.25 M | 104 K | 104 K | 104 K | 104 K | 1.47 M | 1.47 M | 1.47 M | 1.47 M |
Total Inventories |
76 M | 84 M | 94 M | 89.1 M | 95.8 M | 100 M | 132 M | 129 M | 115 M | - | 78.5 M | 86.4 M | 97.9 M | 84.4 M | 73.9 M | 75.2 M | 75.2 M | 75.2 M | 75.2 M | 56.3 M | 56.3 M | 56.3 M | 56.3 M | 24.1 M | 24.1 M | 24.1 M | 24.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency